Literature DB >> 24296172

Replicating damaged DNA in eukaryotes.

Nimrat Chatterjee1, Wolfram Siede.   

Abstract

DNA damage is one of many possible perturbations that challenge the mechanisms that preserve genetic stability during the copying of the eukaryotic genome in S phase. This short review provides, in the first part, a general introduction to the topic and an overview of checkpoint responses. In the second part, the mechanisms of error-free tolerance in response to fork-arresting DNA damage will be discussed in some detail.

Entities:  

Mesh:

Year:  2013        PMID: 24296172      PMCID: PMC3839612          DOI: 10.1101/cshperspect.a019836

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  168 in total

1.  DNA topology, not DNA sequence, is a critical determinant for Drosophila ORC-DNA binding.

Authors:  Dirk Remus; Eileen L Beall; Michael R Botchan
Journal:  EMBO J       Date:  2004-02-05       Impact factor: 11.598

Review 2.  Chk1 in the DNA damage response: conserved roles from yeasts to mammals.

Authors:  Yinhuai Chen; Yolanda Sanchez
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

Review 3.  DNA damage sensing by the ATM and ATR kinases.

Authors:  Alexandre Maréchal; Lee Zou
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

4.  FANCM regulates DNA chain elongation and is stabilized by S-phase checkpoint signalling.

Authors:  Sarah Luke-Glaser; Brian Luke; Simona Grossi; Angelos Constantinou
Journal:  EMBO J       Date:  2009-12-10       Impact factor: 11.598

5.  The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair.

Authors:  Claus Storgaard Sørensen; Lasse Tengbjerg Hansen; Jaroslaw Dziegielewski; Randi G Syljuåsen; Cecilia Lundin; Jiri Bartek; Thomas Helleday
Journal:  Nat Cell Biol       Date:  2005-01-23       Impact factor: 28.824

6.  Regulation of DNA replication fork progression through damaged DNA by the Mec1/Rad53 checkpoint.

Authors:  J A Tercero; J F Diffley
Journal:  Nature       Date:  2001-08-02       Impact factor: 49.962

7.  Yeast DNA repair proteins Rad6 and Rad18 form a heterodimer that has ubiquitin conjugating, DNA binding, and ATP hydrolytic activities.

Authors:  V Bailly; S Lauder; S Prakash; L Prakash
Journal:  J Biol Chem       Date:  1997-09-12       Impact factor: 5.157

8.  Postreplication gaps at UV lesions are signals for checkpoint activation.

Authors:  A John Callegari; Emily Clark; Amanda Pneuman; Thomas J Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

9.  Mutations in the ubiquitin binding UBZ motif of DNA polymerase eta do not impair its function in translesion synthesis during replication.

Authors:  Narottam Acharya; Amrita Brahma; Lajos Haracska; Louise Prakash; Satya Prakash
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

10.  The RecQ helicase WRN is required for normal replication fork progression after DNA damage or replication fork arrest.

Authors:  Julia M Sidorova; Nianzhen Li; Albert Folch; Raymond J Monnat
Journal:  Cell Cycle       Date:  2008-01-04       Impact factor: 4.534

View more
  3 in total

1.  Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancer.

Authors:  Fernanda I Staquicini; Ming D Qian; Ahmad Salameh; Andrey S Dobroff; Julianna K Edwards; Daniel F Cimino; Benjamin J Moeller; Patrick Kelly; Maria I Nunez; Ximing Tang; Diane D Liu; J Jack Lee; Waun Ki Hong; Fortunato Ferrara; Andrew R M Bradbury; Roy R Lobb; Martin J Edelman; Richard L Sidman; Ignacio I Wistuba; Wadih Arap; Renata Pasqualini
Journal:  J Biol Chem       Date:  2015-01-26       Impact factor: 5.157

2.  Rad5 template switch pathway of DNA damage tolerance determines synergism between cisplatin and NSC109268 in Saccharomyces cerevisiae.

Authors:  Dilip Jain; Wolfram Siede
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

3.  Blockade of AXL activation overcomes acquired resistance to EGFR tyrosine kinase inhibition in non-small cell lung cancer.

Authors:  Feng Wang; Xuewen Liu; Boris A Bartholdy; Haiying Cheng; Balazs Halmos
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.